IRIS
D'AMBROSI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.640
AS - Asia 1.707
EU - Europa 1.308
SA - Sud America 287
AF - Africa 41
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.579
SG - Singapore 797
CN - Cina 304
RU - Federazione Russa 269
BR - Brasile 241
IT - Italia 226
HK - Hong Kong 214
DE - Germania 171
VN - Vietnam 141
IE - Irlanda 116
UA - Ucraina 90
GB - Regno Unito 89
JP - Giappone 83
FR - Francia 68
SE - Svezia 66
FI - Finlandia 63
PL - Polonia 45
CA - Canada 41
IN - India 40
KR - Corea 27
NL - Olanda 24
ES - Italia 21
ID - Indonesia 19
AR - Argentina 16
CZ - Repubblica Ceca 15
IQ - Iraq 14
BD - Bangladesh 13
ZA - Sudafrica 12
AU - Australia 10
CI - Costa d'Avorio 10
EC - Ecuador 10
MX - Messico 10
TR - Turchia 10
PK - Pakistan 9
IL - Israele 8
AT - Austria 6
UZ - Uzbekistan 6
JM - Giamaica 5
LT - Lituania 5
PY - Paraguay 5
VE - Venezuela 5
BE - Belgio 4
CH - Svizzera 4
DK - Danimarca 4
GR - Grecia 4
KE - Kenya 4
PT - Portogallo 4
CO - Colombia 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
EG - Egitto 2
HR - Croazia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
NP - Nepal 1
NR - Nauru 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 11.997
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.993
Houston 1.650
Wilmington 1.621
Singapore 480
Fairfield 402
Ashburn 335
San Jose 235
Hong Kong 213
Chandler 191
Ann Arbor 187
Seattle 178
Beijing 130
Cambridge 127
Dublin 110
New York 84
Medford 83
Rome 82
Jacksonville 80
Santa Clara 76
Los Angeles 71
The Dalles 66
Munich 64
Tokyo 61
Council Bluffs 58
Ho Chi Minh City 46
Lawrence 40
Dearborn 39
Moscow 39
Buffalo 36
Hanoi 35
Dallas 34
Helsinki 29
Lauterbourg 29
Kraków 27
São Paulo 26
London 22
Falls Church 19
Denver 18
San Diego 17
Warsaw 16
Milan 15
Pune 15
Frankfurt am Main 13
Toronto 13
Brooklyn 12
Chicago 12
Montreal 12
Mülheim 12
North Bergen 12
Orem 12
Poplar 12
Turku 12
Amsterdam 11
Atlanta 11
Brno 11
Jakarta 11
Abidjan 10
Charlotte 10
Nuremberg 10
Phoenix 10
Stockholm 10
Columbia 9
Menlo Park 9
Mountain View 9
Norwalk 9
Salt Lake City 9
Shenzhen 9
Brasília 8
Johannesburg 8
Ankara 7
Boston 7
Redondo Beach 7
Seoul 7
Amagasaki 6
Lappeenranta 6
Leeds 6
Pittsburgh 6
Rio de Janeiro 6
San Mateo 6
Zibo 6
Belo Horizonte 5
Boardman 5
Campinas 5
Chennai 5
City of London 5
Da Nang 5
Del Norte 5
Haiphong 5
Redwood City 5
Rostock 5
Shanghai 5
St Louis 5
Sydney 5
Asunción 4
Baghdad 4
Brussels 4
Columbus 4
Detroit 4
Joinville 4
Mexico City 4
Totale 9.528
Salva come PNG Salva come JPEG
Nome #
Copper at synapse: Release, binding and modulation of neurotransmission 515
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 490
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 480
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. 461
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 459
ALS: focus on purinergic signalling 457
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue 455
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 437
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 430
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis 423
Pathways to mitochondrial dysfunction in ALS pathogenesis 421
P2 receptor modulation and cytotoxic function in cultured CNS neurons 406
Differences in the neurotoxicity profile induced by ATP and ATP gamma S in cultured cerebellar granule neurons 393
The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells 373
Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators 354
Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists 343
The S100B story: from biomarker to active factor in neural injury 308
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation 305
Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells 245
UsnRNP trafficking is regulated by stress granules and compromised by mutant ALS proteins 207
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis 178
Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis 168
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation 163
Ablation of p2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis 162
Commentary: multifactoriality of amytrophic lateral sclerosis: linking unfolded proteins to oxidative stress in microglia 149
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches 142
Purinergic signaling: A common pathway for neural and mesenchymal stem cell maintenance and differentiation 142
Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis 139
Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis 135
The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93AModels, and Its Inhibition Decreases the Expression of Proinflammatory Genes 130
COntribution of S100A4-regulated pathways to inflammation in ALS models 117
Lipid catabolism and mitochondrial uncoupling are stimulated in brown adipose tissue of amyotrophic lateral sclerosis mouse models 117
UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor 113
Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism 98
Purinergic signalling at the plasma membrane: A multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis 93
N-acetylaspartate mitigates pro-inflammatory responses in microglial cells by intersecting lipid metabolism and acetylation processes. 91
Fibrotic Scar in Neurodegenerative Diseases 90
Fibrosis as a common trait in amyotrophic lateral sclerosis tissues 84
Loss of homeostatic functions in microglia from a murine model of Friedreich's ataxia 82
Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells 81
Cytoplasmic accumulation of a splice variant of hnRNPA2/B1 contributes to FUS-associated toxicity in a mouse model of ALS 81
The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells 79
The Contribution of Non-Neuronal Cells in Neurodegeneration: From Molecular Pathogenesis to Therapeutic Challenges 79
Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems 75
C9orf72 Toxic Species Affect ArfGAP-1 Function 71
Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models 71
P2 receptor web: complexity and fine-tuning 71
Extracellular ATP and neurodegeneration 71
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models 70
S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System 69
Niclosamide Targets Inflammatory and Profibrotic Pathways in Amyotrophic Lateral Sclerosis 67
Receptor webs: can the chunking theory tell us more about it? 65
Metabotropic purinergic receptors in lipid membrane microdomains 62
Targeting S100A4 to study the macrophages-muscle cells cross-talk in models of Duchenne Muscular Dystrophy 61
P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death 59
Neuroinflammation in Friedreich's Ataxia 59
Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors 57
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia 57
Targeting S100A4 to improve inflammation and fibrosis in Duchenne Muscular Dystrophy 56
CYTOPLASMIC AGGREGATION OF WT TDP-43 AND FUS P525L CAUSES GENOME DAMAGE IN A CELLULAR MODEL SYSTEM OF ALS 55
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells 53
Do ATP and NO interact in the CNS? 52
Protein cooperation: from neurons to networks 51
Inflammation in the CNS and PNS: From Molecular Basis to Therapy 49
Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones 44
Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters 43
Biochemical dissection of STAT3 signaling in amyotrophic lateral sclerosis 41
Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation 40
Repurposing niclosamide for the treatment of neurological disorders 38
Repurposing niclosamide to target inflammatory and fibrotic pathways to affect ALS 17
PATHOGENIC FUS PROMOTES THE EXPRESSION OF AGGREGATION-PRONE SPLICING ISOFORMS OF HNRNPA2B1 IN AMYOTROPHIC LATERAL SCLEROSIS 15
Niclosamide ameliorates disease progression in models of amyotrophic lateral sclerosis 15
Targeting S100A4 to modulate inflammation and improve muscle regeneration in Duchenne muscular dystrophy 14
Niclosamide reprograms macrophages and improves muscle integrity in Duchenne muscular dystrophy models 14
Totale 12.257
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 53 19
2021/2022418 17 48 14 21 17 43 22 11 54 25 28 118
2022/2023579 45 42 8 55 57 120 46 26 60 2 33 85
2023/2024267 29 7 22 11 47 90 15 3 5 8 7 23
2024/20251.395 55 296 132 94 12 117 162 56 80 85 127 179
2025/20262.709 261 135 302 323 246 118 330 388 329 274 3 0
Totale 12.257